Chargement de l’entreprise
Just reported
Q3 FY2027 results
From Usana Health Sciences's results release of 3 novembre 2026; its quarterly report has since been filed.
Revenue
Actual
205,9M $US
-3,6 % y/y
-7,8 % q/qGuided
—
No guide given
EPS, GAAP
Actual
-0,30 $US
Guided
—
No guide given
Operating income, GAAP
Actual
-1,4M $US
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Usana Health Sciences is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Packaged Foods
Graded A or B and worth $2B or more: A first, then the largest.
SJMJ M Smucker Co14,2B $USA
MKCMccormick & Company, Incorporated12,7B $USA+
FRPTFreshpet, Inc.3,3B $USA
DARDarling Ingredients Inc.8,7B $USB+
POSTPost Holdings, Inc.3,6B $USB
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA30 juil. 2026BAGraded B, now A
MDLZMondelez International, Inc.29 oct. 2026CAGraded C, now A
HSYHershey Co.29 oct. 2026BAGraded B, now A
SYYSysco Corporation4 nov. 2026BAGraded B, now A
ELFe.l.f. Beauty, Inc.4 nov. 2026BAGraded B, now A
Construit à partir des documents déposés par Usana Health Sciences, Inc. auprès de la Securities and Exchange Commission (SEC), le gendarme boursier américain. Les chiffres sont tels que publiés, l’historique par action étant retraité sur la base d’actions d’aujourd’hui. Ceci décrit une entreprise — ce n’est pas un conseil en investissement ni une recommandation d’acheter ou de vendre.
